Antiviral Research

SJR Rank #2,937H-index: 162SJR: 1.353Best quartile: Q1APC: US$4,160
Journal website: aims, scope and author guidelines
Publisher

Elsevier B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.450.91.351.8

Subject Categories

  • PharmacologyQ1
  • VirologyQ1

Areas: Immunology and Microbiology · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Herpesvirus Infections and TreatmentsHIV/AIDS drug development and treatmentHIV Research and TreatmentCytomegalovirus and herpesvirus researchHepatitis C virus researchHepatitis B Virus StudiesVirus-based gene therapy researchInfluenza Virus Research StudiesViral Infections and Immunology ResearchMosquito-borne diseases and control

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

2022202504590135180

Detailed Information

ISSN

0166-3542, 1872-9096

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.29

References per Document

60.31

Coverage

1959, 1981-2026

Scope

Antiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals. Its scope encompasses: antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action; new or improved vaccines against viral infections of humans; assessments of drug and vaccine safety; evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures; identification and validation of new drug targets; laboratory animal models of viral diseases; pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses.

Metrics from SCImago Journal Rank 2025. View on SCImago